What does the Congenital Adrenal Hyperplasia (HSD3B2) Gene Panel test include?
This panel analyzes the HSD3B2 gene for pathogenic variants that may cause congenital adrenal hyperplasia.
How does Metropolis Healthcare perform this test?
Metropolis Healthcare employs NGS technology with validated bioinformatics pipelines to detect HSD3B2 mutations accurately from EDTA blood samples.
Who should take this test?
Individuals with clinical suspicion of CAH, abnormal hormone levels, or a family history of adrenal disorders may be advised to undergo this test.
What sample type is required?
An EDTA anticoagulated blood sample is needed to ensure high-quality DNA for precise sequencing.
Why is HSD3B2 gene testing important?
Identifying mutations in HSD3B2 confirms the diagnosis of CAH, guides treatment strategies, and supports genetic counseling for families.
How reliable are results from Metropolis Healthcare?
Metropolis Healthcare follows strict quality control protocols, validated NGS platforms, and expert interpretation to deliver accurate and dependable results.
Is any preparation needed before the test?
No special preparation or fasting is required, but patients should follow any instructions provided by their physician.
How soon are results available?
Turnaround time may vary due to sequencing complexity, but Metropolis Healthcare aims to provide timely and comprehensive reports to guide clinical management.